Association of Obesity and Cancer Risk in Canada

American Journal of Epidemiology

Volumn 159, Issue 3, 2004, Pages 259-268

  Pan, Sai Yi ^a,d   Johnson, Kenneth C ^a   Ugnat, Anne Marie ^a   Wen, Shi Wu ^b,c   Mao, Yang ^a  

^a CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Centre for Chronic Disease Prevention and Control   (Canada)

Author keywords

Body mass index; Case control studies; Neoplasms; Obesity

Indexed keywords

CANCER;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANADA; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; KIDNEY CANCER; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; OBESITY; OVARY CANCER; PANCREAS CANCER; POPULATION RESEARCH; POSTMENOPAUSE; PROSTATE CANCER; RECTUM CANCER;

ADULT; AGED; BODY MASS INDEX; CANADA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; SMOKING; SOMATOMEDINS;

EID: 0942290570     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh041     Document Type: Article

References (62)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
2. Life in the 21st century-a vision for all. The world health report. Geneva, Switzerland: World Health Organization, 1998.
3. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
4. McCann J. Obesity, cancer links prompt new recommendations. J Natl Cancer Inst 2001;93:901-2.
5. Statistics Canada. Canadian Community Health Survey: a first look. Ottawa, Canada: Statistics Canada, 2002. (Catalog no. 11-001E).
6. Seidell JC. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 2000;83(suppl 1):S5-8.
7. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-8.
8. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003;289:187-93.
9. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999;31(suppl):S663-7.
10. Seidell JC. The impact of obesity on health status: some implications for health care costs. Int J Obes Relat Metab Disord 1995;19(suppl 6):S13-16.
11. Josefson D. Obesity and inactivity fuel global cancer epidemic. BMJ 2001;322:945.
12. Birmingham CL, Muller JL, Palepu A, et al. The cost of obesity in Canada. CMAJ 1999;160:483-8.
13. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565-74.
14. Ainsworth BE, Jacobs DR Jr, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
15. Anshel MH, Freedson P, Hamill J, et al. Dictionary of the sports and exercise sciences. Champaign, IL: Human Kinetics Publishers, 1991.
16. Gammon MD, Schoenberg JB, Britton JA, et al. Recreational physical activity and breast cancer risk among women under age 45 years. Am J Epidemiol 1998;147:273-80.
17. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
18. Willett WC. Nutritional epidemiology. 2nd ed. New York, NY: Oxford University Press, 1998.
19. Health Canada. Nutrient value of some common foods. Ottawa, Canada: Public Works and Government Services Canada, 1999.
20. Meyer HE, Sogaard AJ, Tverdal A, et al. Body mass index and mortality: the influence of physical activity and smoking. Med Sci Sports Exerc 2002;34:1065-70.
21. Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
22. Moller H, Mellemagaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-50.
23. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976;32:829-49.
24. Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
25. Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921-9.
26. Gapstur SM, Gann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000;283:2552-8.
27. Coughlin SS, Calle EE, Patel AV, et al. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000;11:915-23.
28. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001;21:7-25.
29. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
30. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study on direct interviews. J Natl Cancer Inst 1998;90:1710-19.
31. Ji BT, Hatch MC, Chow WH, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 1996;66:432-7.
32. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, et al. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands. Int J Cancer 1992;52:24-9.
33. Moyad MA. Is obesity a risk factor for prostate cancer, and does it even matter?. A hypothesis and different perspective. Urology 2002;59(suppl 4A):41-50.
34. Rodriguez C, Patel AV, Calle EE, et al. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001;10:345-53.
35. Hsing AW, Deng J, Sesterhenn IA, et al. Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 2000;9:1335-41.
36. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, et al. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-8.
37. Schouten LJ, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 2003;157:424-33.
38. Purdie DM, Bain CJ, Webb PM, et al. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 2001;12:855-63.
39. Lukanova A, Toniolo P, Lundin E, et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 2002;99:603-8.
40. Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control 1994;5:479-83.
41. Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst 1985;74:319-23.
42. Henley SJ, Flanders WD, Manatunga A, et al. Leanness and lung cancer risk: fact or artifact? Epidemiology 2002;13:268-76.
43. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-38.
44. Okasha M, McCarron P, McEwen P, et al. Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Community Health 2002;56:780-4.
45. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
46. World Cancer Research Fund, American Institute of Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute of Cancer Research, 1997.
47. Gupta K, Krishnaswamy G, Karnad A, et al. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002;323:140-5.
48. Furstenberger G, Senn H. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
49. Khandwala HM, McCutcheon IE, Flyvbjerg A, et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21:215-44.
50. Shi R, Berkel HJ, Yu H. Insulin-like growth factor-I and prostate cancer: a meta-analysis. BMJ 2001;85:991-6.
51. Key TJ, Allen NE, Verkasalo PK, et al. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001;60:81-9.
52. Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr 2002;132(suppl):3451S-5S.
53. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-82.
54. Dickson RB, Thompson EW, Lippman ME. Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol Biol 1990;37:305-16.
55. Lacey JV, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002;288:334-41.
56. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis considering the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
57. Noble RL. The development of prostate adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37:1929-33.
58. Eaton NE, Reeves GK, Appleby PN, et al. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 1999;80:930-4.
59. Moyad MA. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol 2001;19:270-9.
60. Chandra RK. Nutrition and the immune system: ann introduction. Am J Clin Nutr 1997;66:460S-3S.
61. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 1994;52:3-50.
62. Hotzel D. Suboptimal nutritional status in obesity (selected nutrients). Bibl Nutr Dieta 1986;37:36-41.